These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7281857)

  • 61. In response to Tong TC, et al. Comparative treatment of alpha-amanitin poisoning with N-acetylcysteine, benzylpenicillin, cimetidine, thioctic acid, and silybin in a murine model.
    Salhanick SD; Wax PM; Schneider SM
    Ann Emerg Med; 2008 Aug; 52(2):184-5; author reply 185. PubMed ID: 18655926
    [No Abstract]   [Full Text] [Related]  

  • 62. [The use of silymarin and SAMe in the treatment of acute infective hepatitis in childhood].
    Musso A; Giacchino M; Vietti M; Vaccino P; Cerutti A
    Minerva Pediatr; 1980 Sep; 32(17):1057-67. PubMed ID: 7453688
    [No Abstract]   [Full Text] [Related]  

  • 63. [Ambulatory treatment of hepatic damage: comparison of 2 therapeutic modalities].
    Ravetta A
    Clin Ter; 1981 Oct; 99(2):149-53. PubMed ID: 7318368
    [No Abstract]   [Full Text] [Related]  

  • 64. [Alcoholic hepatopathy. Aspects of drug therapy].
    Del Dotto M; Neri D
    G Clin Med; 1982 Apr; 63(4):228-36. PubMed ID: 7128979
    [No Abstract]   [Full Text] [Related]  

  • 65. [Clinical study of the therapeutic action of silymarin in acute infectious hepatitis in childhood].
    Mingrino F; Tosti U; Anania S; Buglioni MC; Viola F
    Minerva Pediatr; 1979 Mar; 31(6):451-6. PubMed ID: 470888
    [No Abstract]   [Full Text] [Related]  

  • 66. Effects of silymarin on UDP-glucuronic acid and glucuronidation activity in the rat isolated hepatocytes and liver in relation to D-galactosamine toxicity.
    Chrungoo VJ; Reen RK; Singh K; Singh J
    Indian J Exp Biol; 1997 Mar; 35(3):256-63. PubMed ID: 9332170
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Sylimarine in the treatment of chronic hepatitis].
    Sawaryn T; Szymoński K; Machalska M
    Przegl Epidemiol; 1977; 31(4):445-50. PubMed ID: 607279
    [No Abstract]   [Full Text] [Related]  

  • 68. [Haemorrhagic liver necrosis and signs of shock during phalloidin intoxication (author's transl)].
    Agostini B; Wieland H; Zimmermann R; Hofmann W
    Verh Dtsch Ges Pathol; 1978; 62():260-5. PubMed ID: 746842
    [No Abstract]   [Full Text] [Related]  

  • 69. [Elimination of drugs in cholecystectomized patients. Studies with silymarin in patients with extrahepatic complications].
    Lorenz D; Mennicke WH
    Methods Find Exp Clin Pharmacol; 1981; 3 Suppl 1():103-106S. PubMed ID: 7321653
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Effect of the administration of silymarin on serum lipid levels].
    Petronelli A; Roda E; Briganti M; Morselli Labate AM; Barbara L
    Clin Ter; 1981 Dec; 99(5):471-82. PubMed ID: 7333068
    [No Abstract]   [Full Text] [Related]  

  • 71. [Legalon in the complex treatment of patients with hepatic stasis in chronic circulatory insufficiency].
    Krylov AA
    Vrach Delo; 1984 Mar; (3):22-3. PubMed ID: 6719894
    [No Abstract]   [Full Text] [Related]  

  • 72. Anatamanide protects hepatocytes from phalloidin destruction.
    Faulstich H; Wieland T; Walli A; Birkmann K
    Hoppe Seylers Z Physiol Chem; 1974 Sep; 355(9):1162-3. PubMed ID: 4480436
    [No Abstract]   [Full Text] [Related]  

  • 73. [Liver-protective substances, dietary treatment and cures in the treatment of hepatic diseases (author's transl)].
    Egger G
    Ther Umsch; 1978 Sep; 35(9):761-5. PubMed ID: 360478
    [No Abstract]   [Full Text] [Related]  

  • 74. [Ultrastructural stereological analysis of mouse-like rodent liver from regions with different levels of man-made pollution].
    Nepomniashchikh LM; Lushnikova EL; Molodykh OP
    Biull Eksp Biol Med; 1996 Apr; 121(4):470-6. PubMed ID: 8829472
    [No Abstract]   [Full Text] [Related]  

  • 75. Resolution of liver fibrosis in chronic CCl4 administration in the rat after discontinuation of treatment: effect of silymarin, silibinin, colchicine and trimethylcolchicinic acid.
    Muriel P; Moreno MG; Hernández Mdel C; Chávez E; Alcantar LK
    Basic Clin Pharmacol Toxicol; 2005 May; 96(5):375-80. PubMed ID: 15853930
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Therapy of hepatoses. Therapeutic use of Silymarin].
    Schopen RD; Lange OK
    Med Welt; 1970 Apr; 15():691-8. PubMed ID: 5523243
    [No Abstract]   [Full Text] [Related]  

  • 77. [Aspects of liver damage after experimental administration of some drugs. Preliminary note].
    Martines G; Copponi V; Cagnetta G
    Arch Sci Med (Torino); 1980; 137(3):367-86. PubMed ID: 7235927
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Antihepatoxic constituents of Garcinia kola seeds.
    Iwu MM
    Experientia; 1985 May; 41(5):699-700. PubMed ID: 3838940
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Bioavailability of silymarin, I: Volumes of distribution of silybin, silydianin, and silychristin from in-vitro data (author's transl)].
    Koch HP; Ritschel WA
    Arch Pharm (Weinheim); 1981 Jun; 314(6):515-7. PubMed ID: 7283681
    [No Abstract]   [Full Text] [Related]  

  • 80. Ultrastructural changes in beta-cells of pancreatic islets in alpha-amanitin-poisoned mice.
    Derenzini M; Betts CM; Busi C; Fiume L
    Virchows Arch B Cell Pathol; 1978 Jul; 28(1):13-20. PubMed ID: 97854
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.